Literature DB >> 4465449

A retrospective survey of the complications of mumps.

.   

Abstract

A retrospective survey is described of 2,482 cases of mumps (1,513 males and 969 females) treated in a number of infectious disease units in England and Wales. About half the patients were under 15 years of age. Complications were recorded in 42 per cent of all cases (53 per cent of males and 25 per cent of females), the commonest complication in both sexes being involvement of the central nervous system. Three patients died, but in two of these there was serious underlying illness unrelated to mumps and in the remaining case a review of the records suggests, in retrospect, some doubt about the diagnosis of mumps. Deafness due to involvement of the eighth cranial nerve was the only permanent sequel recorded and occurred in five patients.From the results of this survey it is concluded that there is little need for general vaccination against mumps, although there might be an indication for vaccinating certain groups of the male population.

Entities:  

Mesh:

Year:  1974        PMID: 4465449      PMCID: PMC2157395     

Source DB:  PubMed          Journal:  J R Coll Gen Pract        ISSN: 0035-8797


  8 in total

1.  Para-infectious encephalomyelitis and related syndromes; a critical review of the neurological complications of certain specific fevers.

Authors:  J L GIBBONS; H G MILLER; J B STANTON
Journal:  Q J Med       Date:  1956-10

2.  Surveillance of mumps in the United States as background for use of vaccine.

Authors:  J J Witte; A W Karchmer
Journal:  Public Health Rep       Date:  1968-02       Impact factor: 2.792

3.  Mumps vaccination in the Finnish defense forces.

Authors:  K Penttinen; K Cantell; P Somer; A Poikolainen
Journal:  Am J Epidemiol       Date:  1968-09       Impact factor: 4.897

4.  Mumps and acute tubular necrosis.

Authors:  F Dastur
Journal:  Practitioner       Date:  1968-11

5.  Mumps meningoencephalitis in children.

Authors:  P H Azimi; H G Cramblett; R E Haynes
Journal:  JAMA       Date:  1969-01-20       Impact factor: 56.272

6.  [Significance of mumps meningitis].

Authors:  H Radl
Journal:  Dtsch Med Wochenschr       Date:  1969-08-08       Impact factor: 0.628

7.  Mumps orchitis and sterility.

Authors:  G D McKendrick; T Nishtar
Journal:  Public Health       Date:  1966-09       Impact factor: 2.427

8.  Live attenuated mumps-virus vaccine. IV. Protective efficacy as measured in a field evaluation.

Authors:  M R Hilleman; R E Weibel; E B Buynak; J Stokes; J E Whitman
Journal:  N Engl J Med       Date:  1967-02-02       Impact factor: 91.245

  8 in total
  5 in total

1.  The association between the incidence of mumps and meteorological parameters in Taiwan.

Authors:  Yi-Chien Ho; Bo-Hua Su; Huey-Jen Su; Hsiao-Ling Chang; Chuan-Yao Lin; Huifen Chen; Kow-Tong Chen
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Epidemiologic features of mumps in Taiwan from 2006 to 2011: a new challenge for public health policy.

Authors:  Chian-Ching Chen; Chien-Chih Lu; Bo-Hua Su; Kow-Tong Chen
Journal:  World J Pediatr       Date:  2014-11-22       Impact factor: 2.764

3.  Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control--Guam 2009 to 2010.

Authors:  George E Nelson; Annette Aguon; Engracia Valencia; Rita Oliva; Michele Leon Guerrero; Richard Reyes; Anna Lizama; Daryl Diras; Annakutty Mathew; E Jessica Camacho; Moryne-Nicole Monforte; Tai-Ho Chen; Abdirahman Mahamud; Preeta K Kutty; Carole Hickman; William J Bellini; Jane F Seward; Kathleen Gallagher; Amy Parker Fiebelkorn
Journal:  Pediatr Infect Dis J       Date:  2013-04       Impact factor: 2.129

4.  Reemergence of mumps.

Authors:  Kyong Min Choi
Journal:  Korean J Pediatr       Date:  2010-05-31

Review 5.  Mumps Orchitis: Clinical Aspects and Mechanisms.

Authors:  Han Wu; Fei Wang; Dongdong Tang; Daishu Han
Journal:  Front Immunol       Date:  2021-03-18       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.